NCT06166030 (IRPC) is a Phase 3 clinical trial of Nutritional blend (ImmuneRecov). in Long Covid19, sponsored by Federal University of São Paulo.

Who is sponsoring NCT06166030?

NCT06166030 is sponsored by Federal University of São Paulo.

What drugs are being tested in NCT06166030?

Interventions in NCT06166030: Nutritional blend (ImmuneRecov)..

What condition does NCT06166030 study?

NCT06166030 studies Long Covid19, Dietary Supplements, Respiratory Tract Infections, Inflammation.

Is NCT06166030 still recruiting?

NCT06166030 is currently status unknown. Last updated 12 December 2023.

Last reviewed 2023-12-12 · How we verify

NCT06166030: IRPC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS.

Status unknown Phase 3 Last updated 12 December 2023

What this trial tests

Phase 3 trial testing Nutritional blend (ImmuneRecov). in Long Covid19 in 58 participants. Status unknown.

Timeline

10 December 2023

Primary endpoint
10 December 2024

15 December 2024

Quick facts

Lead sponsor	Federal University of São Paulo
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	58
Start date	10 December 2023
Primary completion	10 December 2024
Estimated completion	15 December 2024
Sites	2 locations across Brazil

Drugs / interventions tested

Nutritional blend (ImmuneRecov).

Conditions studied

Long Covid19 — all drugs for Long Covid19 →
Dietary Supplements — all drugs for Dietary Supplements →
Respiratory Tract Infections — all drugs for Respiratory Tract Infections →
Inflammation — all drugs for Inflammation →

Sponsor

Federal University of São Paulo

Who can join

18 and older, any sex, with Long Covid19 or Dietary Supplements. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: COVID-19 left consequences in different organs from months to years requiring different types of rehabilitation. In fact, a severe loss in the lung function, and in the respiratory and peripheral muscle strength is commonly observed in post-COVID-19 patients. Objectives: Thus, the present study investigated whether 30 days of supplementation with a nutritional blend (ImmuneRecov®; composition: whey protein concentrate, astaxanthin, creatine, selenium, vitamin C, glutamic acid, tryptophan, magnesium) would help to minimize the respiratory (lung function) and muscular (respiratory and peripheral muscles) sequelae in post-COVID-19 patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Beyond Antivirals: Alternative Therapies for Long COVID.
Livieratos A, Gogos C, Akinosoglou K. · · 2024 · cited 8× · PMID 39599909 · DOI 10.3390/v16111795
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method).
Dominguez-Pinilla N, González-Granado LI, Gonzaga A, López Diaz M, et al · · 2025 · cited 3× · PMID 40188166 · DOI 10.1186/s13287-025-04289-3

Verify or expand the search:

Other recruiting trials for Long Covid19

Currently open trials in the same condition.

NCT07140094 — Long-Covid-19 Alleviation Through Learning Mindfulness Study · NA · recruiting
NCT05890508 — Electro-acupuncture for Long Covid Neuropsychiatric Symptoms · NA · recruiting
NCT05741112 — The Long COVID-19 Wearable Device Study · NA · recruiting
NCT06633666 — Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms · NA · recruiting

Other Federal University of São Paulo trials

Trials by the same sponsor.

NCT07376811 — Effect Of Sleeping Posture Guidance On Sleep Quality In Patients With Rotator Cuff Syndrome · NA · not yet recruiting
NCT06805656 — Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretrovirals · Phase 2 · not yet recruiting
NCT06970964 — Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before a · NA · completed
NCT06905860 — Intra-articular Infiltration of Platelet-Rich Fibrin vs Corticosteroid in Mild to Moderate Knee Osteoarthritis · Phase 4 · not yet recruiting
NCT06829992 — Effects of Applying Kinesio Tapping on Primary Dysmenorrhea in Football Players · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06166030 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Federal University of São Paulo
Last refreshed: 12 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06166030.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing